AA
TARO

ALPS Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ALPS Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-69,773
Closed -$6.86M – 958
2018
Q3 		$6.86M Buy
69,773
+11,849
+20% +$1.28M 0.05% 134
2018
Q2 		$6.7M Buy
57,924
+4,138
+8% +$455K 0.04% 145
2018
Q1 		$5.31M Buy
53,786
+8,893
+20% +$901K 0.04% 144
2017
Q4 		$4.7M Buy
44,893
+4,995
+13% +$549K 0.03% 143
2017
Q3 		$4.5M Buy
39,898
+2,861
+8% +$311K 0.03% 145
2017
Q2 		$4.15M Buy
37,037
+1,737
+5% +$196K 0.03% 148
2017
Q1 		$4.02M Sell
35,300
-4,133
-10% -$457K 0.03% 147
2016
Q4 		$4.15M Buy
+39,433
New +$4.13M 0.03% 141

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return